MYC and cancer: Expression of CCN1 is significantly elevated in Hi-myc(+) mice vs. age-matched groups of normal or Hi-myc(−) mice, suggesting the potential utility of the cancer-selective tCCN1-Prom for developing oncolytic viruses with concomitant production of a therapeutic cytokine, a CTV-m7 in this model.